BC Week In Review | Apr 16, 2012
Company News

Nuron, Vitruvian Biomedical deal

Vitruvian granted Nuron exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine , a DNA vaccine containing a gene fragment that codes for beta amyloid 42 . The vaccine is in preclinical development to prevent Alzheimer's...
BC Extra | Apr 10, 2012
Company News

Nuron in-licenses preclinical AD vaccine

Vitruvian Biomedical Inc. (Addison, Texas) granted Nuron Biotech Inc. (Exton, Pa.) exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing a gene fragment that codes for beta amyloid 42 . The...
Items per page:
1 - 2 of 2